Longer survival after HIV infection for injecting drug users than for homosexual men: Implications for immunology

AIDS

Volumn 11, Issue 8, 1997, Pages 1007-1012

  Pehrson, PehrOlov ^a   Lindbäck, Stefan ^a   Lidman, Christer ^a   Gaines, Hans ^b   Giesecke, Johan ^b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

Author keywords

HIV 1 infection; Homosexual men; Immune response; Injecting drug users; Prognosis

Indexed keywords

CD4 ANTIGEN; DIDANOSINE; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; ZALCITABINE; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AIDS RELATED COMPLEX; ARTICLE; BISEXUALITY; COHORT ANALYSIS; HOMOSEXUALITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; INTRAVENOUS DRUG ABUSE; LYMPHOCYTE COUNT; MALE; MORTALITY; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; SEROCONVERSION; SURVIVAL TIME;

ADULT; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HOMOSEXUALITY, MALE; HUMANS; MALE; RETROSPECTIVE STUDIES; SUBSTANCE ABUSE, INTRAVENOUS; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 0030924888     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199708000-00009     Document Type: Article

References (16)

1. Biggar RJ and the International Registry of Seroconverters: AIDS incubation in 1891 HIV seroconvertors from different exposure groups. AIDS 1990, 4:1059-1066.
2. Rezza G, Dorrucci M, Pezzotti P, et al.: The seroconversion study of the natural history of HIV infection. In HIV Epidemiology: Models and Methods. Edited by Nicolosi A. New York: Raven Press; 1994:279-289.
3. Blaxhult A, Granath F, Lidman K, Gieseike J: The influence of age on the latency period to AIDS in people infected with HIV through blood transfusion. AIDS 1990, 4:125-129.
4. Jason J, Lui KJ, Ragni MV, Hessol NA, Darrow WW: Risk of developing AIDS in HIV-infected cohorts of hemophilic and homosexual men. JAMA 1989, 261:725-727.
5. Rutherford GW, Lifson AR, Hessol NA, et al.: Course of HIV infection in a cohort of homosexual and bisexual men: an 11 year follow up study. BMJ 1990, 301:1183-1188.
6. Lee CA, Philips AN, Elford J, Janossy G, Griffiths P, Kernoff P: Progression of HIV disease in a haemophilic cohort followed for 11 years and the effect of treatment. BMJ 1991, 303:1093-1096.
7. Ward JW, Bush TJ, Perkins HA, et al.: The natural history of transfusion-associated infection with human immunodeficiency virus. N Engl J Med 1989, 321:947-952.
8. Giesecke J, Scalia-Tomba G-P, Berglund O, Berntorp E, Schulman S, Stigendal L: Incidence of symptoms and AIDS in 146 Swedish haemophiliacs and blood transfusion recipients infected with human immunodeficiency virus. BMJ 1988, 297:99-102.
9. Chaisson RE, Keruly JC, Moore RD: Race, sex, drug use, and progression of human immunodeficiency virus disease. N Enngl J Med 1995, 333:751-756.
10. Osmond D, Charlebois E, Lang W, Shiboski S, Moss A: Changes in AIDS survival time in two San Francisco cohorts of homosexual men, 1983 to 1993. JAMA 1994, 271:1083-1087.
11. 6/I, AIDS and death from AIDS? BMJ 1994, 309:1535-1537.
12. Sinicco A, Fora R, Sciandra M: Risk of developing AIDS after primary acute HIV-1 infection. J Acquir Immune Defic Syndr 1993, 6:575-581.
13. Dorucci M, Rezza G, Vlahov D, et al.: Clinical characteristics and prognostic value of acute retroviral syndrome among injecting drug users. AIDS 1995, 9:597-604.
14. Tindall B, Cooper DA: Primary HIV infection: host responses and intervention strategies. AIDS 1991, 5:1-14.
15. Albert J, Wahlberg J, Leitner T, Escanilla D, Uhlén M: Analysis of a rape case by direct sequencing of the human immunodeficiency virus type 1 pol and gag genes. J Virol 1994, 68:5918-5924.
16. Putkonen P, Kaaya EE, Böttiger D: Clinical features and predictive markers of disease progression in cynomolgus monkeys experimentally infected with simian immunodeficiency virus. AIDS 1992, 6:257-263.